首页> 外文期刊>Drug development and industrial pharmacy >Preparation and evaluation of erythromycin fumarate--a new derivative of erythromycin.
【24h】

Preparation and evaluation of erythromycin fumarate--a new derivative of erythromycin.

机译:红霉素富马酸霉素的制备与评价 - 红霉素新衍生物。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Erythromycin fumarate, a new water-soluble derivative of erythromycin, was prepared and its physicochemical and biological properties were evaluated. The derivative also has considerable solubility in organic solvents. Its partition coefficient data in different organic solvent-water systems may indicate that it is well-distributed in various tissues in vivo. Antimicrobial potency in vitro of the derivative, 725 micrograms/mg, is much higher than that of the existing derivatives and its antimicrobial spectrum is comparable to that of the parent antibiotic. The LD50 value of the new derivative in mice intraperitoneally is 402.7 mg/kg. Results of this and the previous investigation on pharmacokinetics and protein binding indicate that erythromycin fumarate has high potential for possible clinical application and further investigation may be undertaken.
机译:制备红霉素富马酸霉素,制备了一种新的红霉素的新水溶性衍生物,并评价其物理化学和生物学性质。 衍生物在有机溶剂中也具有相当大的溶解度。 其不同的有机溶剂 - 水系统中的分区系数数据可以表明它在体内各种组织中分布得很好。 衍生物的体外抗微生物效力,725微克/ mg,远高于现有衍生物的耐药性,其抗微生物谱与亲本抗生素的抗菌谱相当。 腹膜内小鼠的新衍生物的LD50值为402.7mg / kg。 结果和先前对药代动力学和蛋白质结合的研究表明,红霉素富马酸盐具有高潜力,可以进行临床应用,并且可以进行进一步调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号